Thrombotic thrombocytopenic purpura with severe neurological impairment: Remission after Rituximab

Transfusion Medicine

Volumn 21, Issue 2, 2011, Pages 140-143

  Magalini, F ^a   Stella, A ^a   Basaglia, M ^a   Vescovini, R ^a   Sassi, M ^b   Maria Lombardi, A ^c   Sansoni, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Parma Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; IMMUNOGLOBULIN G; PREDNISONE; RITUXIMAB; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; B LYMPHOCYTE; BLOOD SMEAR; BONE MARROW EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; ENZYME ACTIVITY; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LETTER; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; REMISSION; SEROLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTICONVULSANTS; CONSCIOUSNESS DISORDERS; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; EPILEPSY, TONIC-CLONIC; FECAL INCONTINENCE; HALLUCINATIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; URINARY INCONTINENCE; VINCRISTINE;

EID: 79951607436     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01053.x     Document Type: Letter

References (12)

1. Allford, S.L., Hunt, B.J., Rose, P. & Machin, S.J. on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for standards in haematology. (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. British Journal of Haematology, 120, 556-573.
2. Chow, T.W., Turner, N.A., Chintagumpala, M., McPherson, P.D., Nolasco, L.H., Rice, L., Hellums, J.D. & Moake, J.L. (1998) Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. American Journal of Hematology, 57, 293-302.
3. Darabi, K. & Berg, A.H. (2006) Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP. Coagulation and Transfusion Medicine, 125, 592-597.
4. Durand, J.M., Lefevre, P. & Kaplanski, G. (1992) Vincristine for thrombotic thrombocytopenic purpura. Lancet, 340, 977-978.
5. Fakhouri, F., Vernant, J.P., Veyradier, A. et al. (2005) Efficiency of curative and prophylactic treatment with rituximab in ADAMTS-13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood, 106, 1932-1937.
6. Ling, H.T., Field, J.J. & Blinder, M.A. (2009) Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. American Journal of Haematology, 84, 418-421.
7. Rufer, A., Broadmann, D., Gregor, M., Kremer Hovinga, J.A., Lammle, B. & Wvillemin, W.A. (2007) Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. Swiss Medical Weekly, 137, 518-524.
8. Scaramucci, L., Discola, P., Palombo, R. et al. (2009) Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura. Internal Journal of Hematology, 89, 398-399.
9. Scully, M., Cohen, H., Cavenagh, J., Benjamin, S., Starke, R., Killick, S., Mackie, I. & Machin, S.J. (2007) Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. British Journal of Haematology, 136, 451-461.
10. Yomtovian, R., Niklinski, W., Silver, B. Sarode, R. & Tsai, H.M. (2004) Rituximab for a chronic recurring thrombotic thrombocytopenic purpura: a casa report and review of the literature. British Journal of Haematology, 124, 787-795.
11. Zheng, X.L., Kaufman, R.M., Goodnough, L.T. & Sadler, J.E. (2004) Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non idiopathic thrombotic thrombocytopenic purpura. Blood, 103, 4043-4049.
12. Ziman, A., Mitri, M., Klapper, E., Pepkowitz, S.H. & Goldfinger, D. (2005) Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature. Transfusion Practice, 45, 41-49.